Product Code: QRF FDA class 3

Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer

Unknown

The Multi-Analyte Test System with Algorithmic Analysis for Detection of Prostate Cancer is an in vitro diagnostic test system that combines values from multiple assays, with or without additional patient information, to yield a score aiding in the detection of prostate cancer or guiding decisions regarding prostate biopsy. It requires PMA approval as an FDA Class 3 device, reflecting the high risk associated with cancer diagnostic decisions. There is no assigned regulation number, and it is reviewed under the Immunology panel. The device is not an implant and not life-sustaining.

510(k)s
0
FEI Numbers
3
Registration Numbers
3
Unique Applicants
0
Years Active

Research product code QRF in seconds

The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.

Free to try · every answer cites its records

Basic Information

Product Code
QRF
Device Class
FDA class 3
Medical Specialty
Unknown
Review Panel
IM
Submission Type
2

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

Definition

Test system that combines values from multiple assays with/without other patient information to yield a score value for aid in detection of prostate cancer and/or decision for prostate biopsy.

FEI Numbers

This FDA classification entry is associated with 3 FEI numbers. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 3 registration numbers. Click on an entry to view related FDA registrations.